ECM1 and glioblastoma: In order to determine whether the expression of ECM1 was an important prognostic factor for Bru treatment on human primary GBM cells, we collected human GBM tissue samples to culture in vitro, and the cells were then treated with Bru for 12–24 h and subjected to cell viability assay.